Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
Clin Pharmacol Ther. 2011 Oct;90(4):499-501. doi: 10.1038/clpt.2011.196. Epub 2011 Aug 10.
The field of cardiovascular regenerative medicine has made significant strides over the past decade. Clinical trials have demonstrated benefit in acute myocardial infarction (AMI) and chronic heart failure (CHF). As the field has matured, it has defined novel biology and invented an array of therapeutic strategies that are currently under development. In this brief review, we attempt to conceptualize the knowledge to date as well as examine how this knowledge has been translated to various therapeutic strategies.
在过去的十年中，心血管再生医学领域取得了重大进展。临床试验已经证明了其在急性心肌梗死（AMI）和慢性心力衰竭（CHF）中的益处。随着该领域的成熟，它已经定义了新的生物学，并发明了一系列目前正在开发的治疗策略。在这篇简短的综述中，我们试图将迄今为止的知识概念化，并研究这些知识是如何转化为各种治疗策略的。
